Alveo Technologies Inc wins Medlab Middle East’s inaugural Labpreneur competition

Alveo Technologies Inc wins Medlab Middle East’s inaugural Labpreneur competition

Dubai, United Arab Emirates: Alveo Technologies, a USA-based provider of cutting-edge molecular testing and cloud-based data analytics for rapid diagnosis and management of infectious diseases, has won this year’s inaugural Medlab Middle East Labpreneur competition, and with it, a three-month mentorship program with Middle East Venture Partners and complimentary exhibition space at the 2024 edition of Medlab Middle East.

The start-up competition has been created to provide a platform for the most exciting medical laboratory start-ups worldwide. Following an intensive pitch process on the final day of Medlab Middle East, where eight companies took to the stage to showcase the latest innovations addressing the challenges within the medical lab industry, Alveo Technologies Inc has come out on top.

The company has developed the dynamic molecular diagnostic platform, be.well™, which focuses on acute respiratory infections, including COVID-19, Flu A/B and RSV, which can be adapted to detect a wide range of diseases, bacteria, and other pathogens that threaten public health, across all modalities.

During the final, Erik Tyrrell-Knott, Chief Business & Strategy Officer at Alveo Technologies Inc, said: “Our vision is to provide lifesaving medical information to those who need it, at the most critical times — with technology that is flexible, inexpensive, and